17:49 , Aug 3, 2018 |  BC Week In Review  |  Financial News

ReViral raises $55M series B

ReViral Ltd. (Stevenage, U.K.) raised $55 million in a series B round co-led by new investors New Leaf Venture Partners and Novo Ventures. Also participating in the round was fellow new investor Perceptive Advisors and...
21:28 , Aug 1, 2018 |  BioCentury  |  Finance

Safety goes (Re)Viral

The clean safety profile and clinical efficacy of ReViral Ltd.’s respiratory syncytial virus therapy prompted Novo Ventures to co-lead the biotech’s $55 million series B round with fellow new investor New Leaf Venture Partners. The...
08:56 , Aug 1, 2018 |  BC Extra  |  Financial News

ReViral raises $55M series B

ReViral Ltd. (Stevenage, U.K.) raised $55 million in a series B round co-led by new investors New Leaf Venture Partners and Novo Ventures. Also participating in the round was fellow new investor Perceptive Advisors and...
14:42 , Jun 29, 2018 |  BC Week In Review  |  Financial News

Precision BioSciences raises $110M in series B

Genome editing company Precision BioSciences Inc. (Durham, N.C.) raised $110 million in an oversubscribed series B round led by new investor ArrowMark Partners. Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital,...
19:46 , Jun 26, 2018 |  BC Extra  |  Financial News

Precision BioSciences raises $110M in series B

Genome editing company Precision BioSciences Inc. (Durham, N.C.) raised $110 million in an oversubscribed series B round led by new investor ArrowMark Partners. Other new Investors included Franklin Templeton, Cowen Healthcare Investments, Brace Pharma Capital,...
22:27 , Feb 2, 2018 |  BioCentury  |  Finance

Building momentum

Avrobio Inc. parlayed positive clinical data and an aggressive in-licensing strategy into a $60 million series B round that will fund early clinical development of three long-acting lysosomal storage disease candidates. Cormorant Asset Management and...
13:13 , Feb 1, 2018 |  BC Extra  |  Financial News

Cell therapy play Avrobio raises $60M

Avrobio Inc. (Cambridge, Mass.) raised $60 million in a series B round co-led by Cormorant Asset Management and Surveyor Capital. Fellow new investors Aisling, Brace Pharma Capital, Eventide, Morningside and Leerink Partners also participated alongside...
22:53 , May 26, 2017 |  BioCentury  |  Finance

Europe’s bellwether challenge

A healthy biotech ecosystem comprises a continuum from big pharma and bellwether biotechs at the top to private newcos at the bottom, with a mixture of liquidity events -- predominantly M&A -- to reward investors....
05:17 , Mar 31, 2017 |  BC Week In Review  |  Financial News

Antiva Biosciences completes venture financing

On March 28, HPV play Antiva Biosciences Inc. (Menlo Park, Calif.) raised $22 million in a series C round led by new investor Brace Pharma Capital. New investors NS Investment, Osage University Partners and Alexandria...
17:15 , Mar 28, 2017 |  BC Extra  |  Financial News

Antiva raises $22M series C round

Antiva Biosciences Inc. (Menlo Park, Calif.) raised $22 million in a series C round led by new investor Brace Pharma Capital. Also participating were new investors NS Investment, Osage University Partners and Alexandria Venture Investments...